CD276 and acute myeloid leukemia: The improvements observed for CBLB and TIGIT knock-outs in AML could be overshadowed in CD276-CAR-NK-92 cytotoxicity assays by the powerful CAR-driven activation, which almost reached complete lysis of leukemic cells after 6 h of co-culture (Figure 6h).